John L. Higgins

2019

In 2019, John L. Higgins earned a total compensation of $6.8M as Chief Executive Officer at Ligand Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$291,686
Option Awards$2,891,109
Salary$648,192
Stock Awards$2,933,389
Other$6,000
Total$6,770,376

Higgins received $2.9M in stock awards, accounting for 43% of the total pay in 2019.

Higgins also received $291.7K in non-equity incentive plan, $2.9M in option awards, $648.2K in salary and $6K in other compensation.

Rankings

In 2019, John L. Higgins' compensation ranked 1,443rd out of 13,971 executives tracked by ExecPay. In other words, Higgins earned more than 89.7% of executives.

ClassificationRankingPercentile
All
1,443
out of 13,971
90th
Division
Manufacturing
511
out of 5,701
91st
Major group
Chemicals And Allied Products
155
out of 2,200
93rd
Industry group
Drugs
123
out of 1,886
94th
Industry
Pharmaceutical Preparations
93
out of 1,398
93rd

Pay ratio

John L. Higgins' Pay$6,770,376
Median Employee's Pay$109,795
Pay Ratio

62

to 1

In 2019, the annual total compensation of John L. Higgins was $6,770,376.

The annual total compensation of the median employee at Ligand Pharmaceuticals was $109,795.

The ratio of John L. Higgins' pay to the pay of median employee was therefore 62 to one.

Source: SEC filing on November 12, 2020.

Higgins' colleagues

We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2019.

2019

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2019

Matthew Korenberg

Ligand Pharmaceuticals

Chief Financial Officer

2019

Charles Berkman

Ligand Pharmaceuticals

General Counsel

News

You may also like